Back to home page

 


Search RSDSA
Search Web

.
   

 

 

 

Bookmark and Share  
   
What’s New?
 

Physicians for Responsible Opioid Prescribing (PROP) has petitioned the FDA to change labeling on certain opioid analgesics. This could seriously impact your pain management program. The RSDSA has submitted a letter opposing the petition (read the letter). To read the PROP petition, click here.

Act now! Send your own response. Click here.

Things You Should Know

Help Us Work for Your Better Future
Enroll in our study today!

Combined Federal Program (CFC)
The RSDSA participates in the Combined Federal Campaign (CFC), a program that allows pledges made by Federal civilian, postal, and military donors during the campaign season (September 1st to December 15th) to support eligible not-for-profit organizations that provide health and human service benefits throughout the world.

If you are a federal government or military employee and would like to support the work of the RSDSA, please take part in the CFC by entering RSDSA and/or code #11045 on your pledge card.

State-By-State Opiod Prescribing Policies
Prescribing controlled substances involves adherence to federal regulations in addition to stricter requirements imposed by individual states.

Clinical Trials

Clinical trials for complex regional pain syndrome on NHS Choices
Information provided by WHO International Clinical Trials Registry

Regional Anesthesia Military Battlefield Pain Outcomes Study (RAMBPOS)
The purpose of this study is to examine the short and long-term benefits of implementing early advanced regional anesthesia techniques for pain control, such as reducing pain disability and the incidence and severity of mental health disorders, following major traumatic injuries to extremities encountered during combat in the Iraqi/Afghanistan war.

Top of Page

Updated September 13, 2013

 

 

.
© 2011 RSDSA | Please contact the webmaster with questions or comments about this site.